# CARotid plaqUe StabilizatiOn and Regression With Evolocumab.

> **NCT04730973** · PHASE4 · UNKNOWN · sponsor: **Azienda Ospedaliera Ordine Mauriziano di Torino** · enrollment: 130 (estimated)

## Conditions studied

- Carotid Artery Disease

## Interventions

- **DRUG:** Evolocumab
- **OTHER:** lipid-lowering therapy (LLT)

## Key facts

- **NCT ID:** NCT04730973
- **Lead sponsor:** Azienda Ospedaliera Ordine Mauriziano di Torino
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04730973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04730973, "CARotid plaqUe StabilizatiOn and Regression With Evolocumab.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04730973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*